Skip to main content


The Fecal Pancreatic Elastase Testing Market is driven by several factors that contribute to its growth and adoption. Pancreatic insufficiency is a condition characterized by the inadequate production or release of digestive enzymes by the pancreas. The rising prevalence of pancreatic insufficiency, often associated with conditions such as chronic pancreatitis, cystic fibrosis, and liver cancer, is driving the demand for fecal liver elastase testing.